Evidence map›Paper›PMID 25395856›Full record

ArticleNeuropsychiatric disease and treatment2014

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?

Eda Celik Guzel, Esra Bakkal, Savas Guzel, Hasan Emre Eroglu, Ayse Acar, Volkan Kuçukyalcin, Birol Topcu

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Low Concentration of BDNF in the Acute Phase of Ischemic Stroke as a Factor in Poor Prognosis in Terms of Functional Status of Patients.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eda Celik GuzelDepartment of Family Physician, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Esra BakkalDepartment of Family Physician, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Savas GuzelDepartment of Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Hasan Emre ErogluFaculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Ayse AcarDepartment of Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Volkan KuçukyalcinDepartment of Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Birol TopcuDepartment of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Namık Kemal University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDepression is a common condition in obese women that can result in severe impairment of their physical and social functioning. A deficiency of brain-derived neurotrophic factor (BDNF) is involved in the mechanism of depression. The aim of this study is to investigate whether BDNF levels differ between obese female patients and healthy controls and whether BDNF levels alter with affective states in depressive obese women.

methodsThe study group included 40 obese, 40 preobese, and 40 normal weight women. BDNF levels were measured with an enzyme-linked immunosorbent assay in patient and control groups. For identifying the depression and anxiety status, Beck Depression/Anxiety Inventories were used; and for the evaluation of cognitive functions, the mini-mental state examination was used.

resultsBDNF levels were significantly lower in obese patients compared to the control group (P<0.01). BDNF levels were significantly lower in obese patients with depression compared to the obese patients without depression (P<0.05). The Beck Depression Inventory showed a negative correlation with BDNF (r=-0.044; P<0.01) and a positive correlation with the Beck Anxiety Inventory (r=0.643; P<0.001), vitamin B12 levels (r=0.023; P<0.001), and insulin levels (r=0.257; P<0.05) in obese patients. When receiver operating characteristic curve analysis was used to analyze the suitability of BDNF to identify depression in obese women, the area under the curve for BDNF, 0.756, was found to be significant (P=0.025). BDNF levels lower than 70.2 pg/mL were associated with a higher prevalence of depressive symptoms.

conclusionThe results of our study suggest that the decrease in BDNF levels can be used as a marker for depression diagnosis in obese patients.

Indexed as

brain-derived neurotrophic factorcomorbidityobesity

Identifiers

PMID25395856
PMCPMC4226451
OpenAlexW1997787649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.